Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Plesner, A.
Right arrow Articles by Verchere, C. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Plesner, A.
Right arrow Articles by Verchere, C. B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:2533-2540, 2005
© 2005 by the American Diabetes Association, Inc.

The X-Linked Inhibitor of Apoptosis Protein Enhances Survival of Murine Islet Allografts

Annette Plesner1, Peter Liston2, Rusung Tan1, Robert G. Korneluk2, and C. Bruce Verchere1

1 Department of Pathology and Laboratory Medicine, British Columbia Research Institute for Children’s and Women’s Health, University of British Columbia, Vancouver, British Columbia, Canada
2 Department of Pediatrics, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada

Allotransplantation of pancreatic islets represents a promising approach to treat type 1 diabetes. Destruction of ß-cells in islet allografts involves multiple immune mechanisms that lead to activation of caspases and apoptotic cell death. The X-linked inhibitor of apoptosis (XIAP) inhibits apoptosis induced by a variety of triggers, primarily by preventing the activation of caspases. To determine whether XIAP would protect ß-cells from apoptosis, we used a recombinant adenovirus to overexpress XIAP in transformed murine ß-cells and in freshly isolated islets. In vitro cytokine-induced ß-cell death was decreased to baseline levels in XIAP-transduced MIN-6 and NIT-1 cell lines compared with controls. To evaluate the potential of XIAP overexpression to prevent in vivo allogeneic graft rejection, we transduced Balb/c islets ex vivo with XIAP before transplantation into CBA mice with streptozotocin-induced diabetes. We observed that almost all mice receiving allografts of XIAP-expressing islets maintained normoglycemia until the experiment was terminated (45–72 days posttransplant), whereas control mice receiving islets transduced with adenovirus expressing LacZ were hyperglycemic by ~17 days posttransplantation due to graft rejection. Immunohistochemistry revealed preservation of ß-cells and clearance of infiltrating immune cells in the XIAP-expressing islet grafts. The in vitro allogeneic response of splenocytes isolated from recipients of XIAP-expressing grafts 8 weeks posttransplant was similar to that seen in nonprimed allogeneic mice, suggesting that XIAP overexpression may lead to the acceptance of islet allografts in diabetic recipients. Long-term protection of islet allografts by XIAP overexpression may enhance the survival of islet transplants in diabetes.


Address correspondence and reprint requests to Annette Plesner, BC Research Institute for Children’s and Women’s Health, University of British Columbia, Department of Pathology and Laboratory Medicine, Room 2071-950, W. 28th Ave., Vancouver, British Columbia, V5Z 4H4, Canada. E-mail: plesner{at}interchange.ubc.ca

Abbreviations: IFN, interferon; IL, interleukin; MOI, multiplicity of infection; TNF, tumor necrosis factor; XIAP, X-linked inhibitor of apoptosis


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
J. D. Rivas-Carrillo, A. Soto-Gutierrez, N. Navarro-Alvarez, H. Noguchi, T. Okitsu, Y. Chen, T. Yuasa, K. Tanaka, M. Narushima, A. Miki, et al.
Cell-Permeable Pentapeptide V5 Inhibits Apoptosis and Enhances Insulin Secretion, Allowing Experimental Single-Donor Islet Transplantation in Mice
Diabetes, May 1, 2007; 56(5): 1259 - 1267.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. A. Thomas, C. Stauffer, K. Zhao, H. Yang, V. K. Sharma, H. H. Szeto, and M. Suthanthiran
Mitochondrial Targeting with Antioxidant Peptide SS-31 Prevents Mitochondrial Depolarization, Reduces Islet Cell Apoptosis, Increases Islet Cell Yield, and Improves Posttransplantation Function
J. Am. Soc. Nephrol., January 1, 2007; 18(1): 213 - 222.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
G. Harb and G. S Korbutt
Effect of prolonged in vitro exposure to high glucose on neonatal porcine pancreatic islets.
J. Endocrinol., October 1, 2006; 191(1): 37 - 44.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. A. Emamaullee and A.M. J. Shapiro
Interventional Strategies to Prevent {beta}-Cell Apoptosis in Islet Transplantation.
Diabetes, July 1, 2006; 55(7): 1907 - 1914.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.